Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

NCT01122784 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Plague Vaccine

Interventions

BIOLOGICAL: rF1V vaccine (with Adjuvant)
BIOLOGICAL: rF1V vaccine (without Adjuvant)
BIOLOGICAL: rF1V vaccine (with Adjuvant)
BIOLOGICAL: rF1V vaccine (without Adjuvant)

Sponsor

DynPort Vaccine Company LLC, A GDIT Company